Core Alternative Capital Pfizer Inc Transaction History

Core Alternative Capital

$484 Million
Q2 2024

A detailed history of Core Alternative Capital transactions in Pfizer Inc stock. As of the latest transaction made, Core Alternative Capital holds 7,448 shares of PFE stock, worth $195,435. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,448

Previous 7,448 -0.0%

Holding current value

$195,435

Previous $206,000 0.97%

% of portfolio

0.04%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $79,430 - $91,211	-3,068 Reduced 29.17%	7,448 $206,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $29,814 - $38,725	1,141 Added 12.17%	10,516 $302,000
Q3 2023 Oct 19, 2023	BUY	$32.09 - $37.51 $417 - $487	13 Added 0.14%	9,375 $310,000
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $36,878 - $42,667	-1,021 Reduced 9.83%	9,362 $343,000
Q1 2023 Apr 18, 2023	BUY	$39.39 - $51.28 $312,402 - $406,701	7,931 Added 323.45%	10,383 $423,000
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $7,556 - $9,864	-181 Reduced 6.87%	2,452 $125,000
Q3 2022 Oct 18, 2022	BUY	$43.76 - $53.42 $6,870 - $8,386	157 Added 6.34%	2,633 $115,000
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $17,634 - $20,909	379 Added 18.07%	2,476 $130,000
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $59,383 - $73,583	1,298 Added 162.45%	2,097 $109,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $3,718 - $5,512	90 Added 12.69%	799 $47,000
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $27,828 - $35,747	709 New	709 $30,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.

Account

Core Alternative Capital Pfizer Inc Transaction History